Outsmarting Cancer, Impacting lives

A clinical study investigating a potential new treatment for myelofibrosis, a rare type of blood cancer, can now move forward with its next group of patients. The study, known as HOVON 172 or TasqForce, has completed its first safety evaluation under a revised protocol.

Around 1 in 7 women develop breast cancer in their life. As we are closing the October Breast Cancer Awareness month, we reflect with three Oncode Investigators on their contribution to the scientific understanding, prevention and treatment of this disease. 

We spoke with Sylvie Noordermeer about her scientific drive, the defining moments in her work and her hope for the treatment of patients with breast cancer. 

Around 1 in 7 women develop breast cancer in their life. As we are closing the October Breast Cancer Awareness month, we reflect with three Oncode Investigators on their contribution to the scientific understanding, prevention and treatment of this disease. 

We spoke with Wilbert Zwart about his scientific drive, the defining moments in his work and his hope for the treatment of patients with breast cancer.